Dialysis Reimbursement: What Impact Do Different Models Have on Clinical Choices?
Allowing patients to live for decades without the function of a vital organ is a medical miracle, but one that is not without cost both in terms of morbidity and quality of life and in economic terms. Renal replacement therapy (RRT) consumes between 2% and 5% of the overall health care expenditure i...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/8/2/276 |
id |
doaj-4ae49f8143ff4d5ea71a7aa863a60a0b |
---|---|
record_format |
Article |
spelling |
doaj-4ae49f8143ff4d5ea71a7aa863a60a0b2020-11-25T01:00:23ZengMDPI AGJournal of Clinical Medicine2077-03832019-02-018227610.3390/jcm8020276jcm8020276Dialysis Reimbursement: What Impact Do Different Models Have on Clinical Choices?Giorgina Barbara Piccoli0Gianfranca Cabiddu1Conrad Breuer2Christelle Jadeau3Angelo Testa4Giuliano Brunori5Department of Clinical and Biological Sciences, University of Torino Italy, 10100 Torino, ItalyNephrology, Brotzu Hospital, 09100 Cagliari, ItalyDirection, Centre Hospitalier Le Mans, 72000 Le Mans, FranceCentre de Recherche Clinique, Centre Hospitalier Le Mans, 72000 Le Mans, FranceAssociation ECHO, 44000 Nantes, FranceNefrologia, Ospedale di Trento, 38100 Trento, ItalyAllowing patients to live for decades without the function of a vital organ is a medical miracle, but one that is not without cost both in terms of morbidity and quality of life and in economic terms. Renal replacement therapy (RRT) consumes between 2% and 5% of the overall health care expenditure in countries where dialysis is available without restrictions. While transplantation is the preferred treatment in patients without contraindications, old age and comorbidity limit its indications, and low organ availability may result in long waiting times. As a consequence, 30⁻70% of the patients depend on dialysis, which remains the main determinant of the cost of RRT. Costs of dialysis are differently defined, and its reimbursement follows different rules. There are three main ways of establishing dialysis reimbursement. The first involves dividing dialysis into a series of elements and reimbursing each one separately (dialysis itself, medications, drugs, transportation, hospitalisation, etc.). The second, known as the capitation system, consists of merging these elements in a per capita reimbursement, while the third, usually called the bundle system, entails identifying a core of procedures intrinsically linked to treatment (e.g., dialysis sessions, tests, intradialyitc drugs). Each one has advantages and drawbacks, and impacts differently on the organization and delivery of care: payment per session may favour fragmentation and make a global appraisal difficult; a correct capitation system needs a careful correction for comorbidity, and may exacerbate competition between public and private settings, the latter aiming at selecting the least complex cases; a bundle system, in which the main elements linked to the dialysis sessions are considered together, may be a good compromise but risks penalising complex patients, and requires a rapid adaptation to treatment changes. Retarding dialysis is a clinical and economical goal, but the incentives for predialysis care are not established and its development may be unfavourable for the provider. A closer cooperation between policymakers, economists and nephrologists is needed to ensure a high quality of dialysis care.https://www.mdpi.com/2077-0383/8/2/276dialysis reimbursementcostsrenal replacement therapyincremental dialysispredialysis care |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Giorgina Barbara Piccoli Gianfranca Cabiddu Conrad Breuer Christelle Jadeau Angelo Testa Giuliano Brunori |
spellingShingle |
Giorgina Barbara Piccoli Gianfranca Cabiddu Conrad Breuer Christelle Jadeau Angelo Testa Giuliano Brunori Dialysis Reimbursement: What Impact Do Different Models Have on Clinical Choices? Journal of Clinical Medicine dialysis reimbursement costs renal replacement therapy incremental dialysis predialysis care |
author_facet |
Giorgina Barbara Piccoli Gianfranca Cabiddu Conrad Breuer Christelle Jadeau Angelo Testa Giuliano Brunori |
author_sort |
Giorgina Barbara Piccoli |
title |
Dialysis Reimbursement: What Impact Do Different Models Have on Clinical Choices? |
title_short |
Dialysis Reimbursement: What Impact Do Different Models Have on Clinical Choices? |
title_full |
Dialysis Reimbursement: What Impact Do Different Models Have on Clinical Choices? |
title_fullStr |
Dialysis Reimbursement: What Impact Do Different Models Have on Clinical Choices? |
title_full_unstemmed |
Dialysis Reimbursement: What Impact Do Different Models Have on Clinical Choices? |
title_sort |
dialysis reimbursement: what impact do different models have on clinical choices? |
publisher |
MDPI AG |
series |
Journal of Clinical Medicine |
issn |
2077-0383 |
publishDate |
2019-02-01 |
description |
Allowing patients to live for decades without the function of a vital organ is a medical miracle, but one that is not without cost both in terms of morbidity and quality of life and in economic terms. Renal replacement therapy (RRT) consumes between 2% and 5% of the overall health care expenditure in countries where dialysis is available without restrictions. While transplantation is the preferred treatment in patients without contraindications, old age and comorbidity limit its indications, and low organ availability may result in long waiting times. As a consequence, 30⁻70% of the patients depend on dialysis, which remains the main determinant of the cost of RRT. Costs of dialysis are differently defined, and its reimbursement follows different rules. There are three main ways of establishing dialysis reimbursement. The first involves dividing dialysis into a series of elements and reimbursing each one separately (dialysis itself, medications, drugs, transportation, hospitalisation, etc.). The second, known as the capitation system, consists of merging these elements in a per capita reimbursement, while the third, usually called the bundle system, entails identifying a core of procedures intrinsically linked to treatment (e.g., dialysis sessions, tests, intradialyitc drugs). Each one has advantages and drawbacks, and impacts differently on the organization and delivery of care: payment per session may favour fragmentation and make a global appraisal difficult; a correct capitation system needs a careful correction for comorbidity, and may exacerbate competition between public and private settings, the latter aiming at selecting the least complex cases; a bundle system, in which the main elements linked to the dialysis sessions are considered together, may be a good compromise but risks penalising complex patients, and requires a rapid adaptation to treatment changes. Retarding dialysis is a clinical and economical goal, but the incentives for predialysis care are not established and its development may be unfavourable for the provider. A closer cooperation between policymakers, economists and nephrologists is needed to ensure a high quality of dialysis care. |
topic |
dialysis reimbursement costs renal replacement therapy incremental dialysis predialysis care |
url |
https://www.mdpi.com/2077-0383/8/2/276 |
work_keys_str_mv |
AT giorginabarbarapiccoli dialysisreimbursementwhatimpactdodifferentmodelshaveonclinicalchoices AT gianfrancacabiddu dialysisreimbursementwhatimpactdodifferentmodelshaveonclinicalchoices AT conradbreuer dialysisreimbursementwhatimpactdodifferentmodelshaveonclinicalchoices AT christellejadeau dialysisreimbursementwhatimpactdodifferentmodelshaveonclinicalchoices AT angelotesta dialysisreimbursementwhatimpactdodifferentmodelshaveonclinicalchoices AT giulianobrunori dialysisreimbursementwhatimpactdodifferentmodelshaveonclinicalchoices |
_version_ |
1725213765998215168 |